Treatment and prevention of chronic cystitis in women

• Published in: Urologii͡a︡ (Moscow, Russia : 1999) no. 2; p. 51
• Main Authors: Neymark, A I, Razdorslaya, M V, Neymark, B A, Nozdrachev, N A
• Format: Journal Article
• Language: Russian
• Published: Russia (Federation) 01.05.2021
• Subjects: Anti-Bacterial Agents - therapeutic use; Anti-Infective Agents - therapeutic use; Anti-Inflammatory Agents - therapeutic use; Cystitis - drug therapy; Cystitis - prevention & control; Female; Humans; Recurrence; NefroBest; chronic cystitis; herbal uroseptics
• ISSN: 1728-2985
• DOI: 10.18565/urology.2021.2.51-56

to evaluate the efficiency of the dietary supplement NefroBest in women with chronic cystitis. On the basis of the Department of Urology and Nephrology of the Altai State Medical University and the urological department of the NUZ CH "RJD Medicine", Barnaul, from September 2019 to August 2020 a total of 40 women with chronic cystitis were treaeted. Depending on the type of treatment, all women were divided into the main and control groups, each of 20 people. In the main group, patients received standard therapy and dietary supplements NefroBest. In the control group, patients were prescribed only to standard therapy. The results were evaluated one and two months after the start of therapy. In the main group a more rapid resolution of symptoms and laboratory abnormalities were seen, as well as an improvement of the endoscopic picture and urodynamic parameters. The complex of biologically active substances in the dietary supplement NefroBest has an antimicrobial, anti-inflammatory and antispasmodic effect, and reduces the risk of recurrence of chronic cystitis. Thus, the dietary supplement NefroBest can be recommended as a component of the complex therapy of recurrences of chronic cystitis, as well as a prophylactic treatment during relapse-free period.